Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 266K | Omzet 2007 | 180K 169K | Marktkapitalisatie | 42,29 mln. 39,61 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -35,59 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,65 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 56,57 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 30,52 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,54% | 122 mld. | |
+21,49% | 116 mld. | |
+22,18% | 27,03 mld. | |
-21,42% | 20,36 mld. | |
-16,89% | 16,43 mld. | |
-18,34% | 15,91 mld. | |
-44,74% | 15,6 mld. | |
+61,83% | 14,94 mld. | |
+3,31% | 13,59 mld. |